Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations

Clinical trial NCT01359449 · COMPLETED

Trial details

NCT number: NCT01359449
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningitis Meningococcal Infection

Start date: 2011-05-01
Primary completion: 2012-07-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.